A Study of the Safety, Tolerability, and Pharmacokinetics of SM04690 Injectable Suspension Following Single Intradiscal Injection in Subjects With Degenerative Disc Disease
Clinical trial NCT03246399 · TERMINATED
Trial details
- NCT number
- NCT03246399
- Sponsor
- Biosplice Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-26
- Primary completion
- 2018-11-14
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.